Sponsored
CART, CRWD, EXPE, ADI, CCL upgraded on growth & valuation. BSX, HIG, OVV, PTCT, TERN downgraded on risks & estimates.
ASAN's 1.7x P/S & TFX's 16.2x P/E show weak growth; XRAY's 8.2x P/E signals value destruction.
Nasdaq correction! META, ADBE, LYFT trade at deep discounts, offering buying ops despite AI fears.
Eli Lilly inks $2.75B AI drug deal with InSilico. Stock jumps on future growth potential.
CVLT surges on billings growth (26.6%) & high margins (81.4%), trading at 2.8x P/S. WT boasts 18.9% revenue growth & 17% ROE at 13x P/E.
Silver's 2.70% jump sparks rally talk, but geopolitical risks loom. Traders eye $75 target.
DV's 2x P/S valuation faces margin pressure; ZUMZ's 23.4x P/E shows weak ROIC; RELY's 8.8x EV/EBITDA shines with growth.
Sponsored
Must Read